Once produced by cancer cells, prosaposin acts in a paracrine and endocrine fashion inducing the expression of thrombospondin-1 in stromal cells at primary and distant tumor sites, which blocks neoangiogenesis and delays tumor growth (195). The gene discussed is PSAP; the disease is neoplasm.